Menu

Locate a Mesothelioma Cancer Center Near You

  • Information on top cancer centers and doctors
  • Find the right fit for your situation
  • Financial information to help with treatment costs
Get Connected

Completed mesothelioma clinical trials help doctors understand the efficacy of emerging treatment options. In completed clinical trials, all the data has been collected and patients are no longer being tested. Researchers will examine the information collected during the study and draw conclusions about experimental treatments.


01. What Are Completed Clinical Trials?

What Makes a Clinical Trial Complete?

A completed mesothelioma clinical trial is no longer testing treatments on patients.

There are four phases that mesothelioma clinical trials go through. In Phase I new mesothelioma drugs or treatments are tested in a small group of participants. Phase II evaluates the same drug or treatment therapy in a larger group. Phase III involves an even larger population of participants and Phase IV takes place post-licensing and marketing of a new drug or treatment.

02. List of Completed Clinical Trials

Completed Clinical Trials for Mesothelioma

The clinical trials listed below have completed. Please click on a link to learn more about the study and the study results.

Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy


Conditions: Mesothelioma

Last Updated: August 16, 2021

Status: Completed

Locations: Scottsdale, AZ. San Francisco, CA. Hartford, CT. New Britain, CT. Lewes, DE. Newark, DE. Boise, ID. Bloomington, IL. Bloomington, IL. Canton, IL. Carthage, IL. Chicago, IL. Eureka, IL. Eureka, IL. Galesburg, IL. Havana, IL. Kewanee, IL. La Grange, IL. Macomb, IL. Monmouth, IL. Monmouth, IL. Normal, IL. Normal, IL. Normal, IL. Ottawa, IL. Ottawa, IL. Pekin, IL. Pekin, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peru, IL. Peru, IL. Princeton, IL. Spring Valley, IL. Elkhart, IN. Elkhart, IN. Elkhart, IN. Kokomo, IN. La Porte, IN. Mishawaka, IN. Mishawaka, IN. Plymouth, IN. South Bend, IN. South Bend, IN. Westville, IN. Sioux City, IA. Sioux City, IA. Sioux City, IA. Chanute, KS. Dodge City, KS. El Dorado, KS. Fort Scott, KS. Independence, KS. Kingman, KS. Lawrence, KS. Liberal, KS. McPherson, KS. Newton, KS. Parsons, KS. Pratt, KS. Salina, KS. Wellington, KS. Wichita, KS. Wichita, KS. Wichita, KS. Wichita, KS. Wichita, KS. Winfield, KS. Baton Rouge, LA. Covington, LA. New Orleans, LA. New Orleans, LA. New Orleans, LA. Baltimore, MD. Baltimore, MD. Elkton, MD. Ann Arbor, MI. Ann Arbor, MI. Dearborn, MI. Flint, MI. Flint, MI. Grand Blanc, MI. Grosse Pointe Woods, MI. Jackson, MI. Lansing, MI. Livonia, MI. Pontiac, MI. Port Huron, MI. Saginaw, MI. Saint Joseph, MI. Saint Joseph, MI. Warren, MI. Brainerd, MN. Duluth, MN. Duluth, MN. Duluth, MN. Minneapolis, MN. Rochester, MN. Las Vegas, NV. Las Vegas, NV. Voorhees, NJ. East Syracuse, NY. Syracuse, NY. Durham, NC. Goldsboro, NC. Kinston, NC. Statesville, NC. Bismarck, ND. Bismarck, ND. Bismarck, ND. Akron, OH. Barberton, OH. Beachwood, OH. Cleveland, OH. Cleveland, OH. Columbus, OH. Independence, OH. Mayfield Heights, OH. Parma, OH. Sandusky, OH. Strongsville, OH. Wooster, OH. Clackamas, OR. Milwaukie, OR. Newberg, OR. Oregon City, OR. Portland, OR. Portland, OR. Portland, OR. Abington, PA. Danville, PA. Hazleton, PA. Philadelphia, PA. Philadelphia, PA. Pittsburgh, PA. State College, PA. Wilkes-Barre, PA. Charleston, SC. Danville, VA. Vancouver, WA. Vancouver, WA. La Crosse, WI.

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers


Conditions: Lung Neoplasms, Small Cell Lung Carcinoma, Mesothelioma, Bile Duct Neoplasms, Anxiety Disorders

Last Updated: July 22, 2021

Status: Completed

Locations: La Jolla, CA. Honolulu, HI. Chicago, IL. Evanston, IL. Glenview, IL. Highland Park, IL. Iowa City, IA. Boston, MA. Grand Rapids, MI. Minneapolis, MN. Rochester, MN. Saint Louis Park, MN. Saint Paul, MN. Lebanon, NH. New Hyde Park, NY. New York, NY. Durham, NC. Grand Forks, ND. Oklahoma City, OK. Richmond, VA. La Crosse, WI. Marshfield, WI. Milwaukee, WI.

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.


Conditions: Mesothelioma

Last Updated: July 13, 2021

Status: Completed

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)


Conditions: Mesothelioma

Last Updated: June 30, 2021

Status: Completed

Locations: Scottsdale, AZ. Tucson, AZ. Duarte, CA. Chicago, IL. Detroit, MI. Las Vegas, NV. Albuquerque, NM. New York, NY. Cleveland, OH. Hershey, PA. San Antonio, TX. Salt Lake City, UT.

Alvopem® (Pemetrexed) Safety Assessment


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma

Last Updated: April 10, 2021

Status: Completed

Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.


Conditions: Neoplasms

Last Updated: April 6, 2021

Status: Completed

Locations: New York, NY. New York, NY. Durham, NC. Houston, TX. San Antonio, TX. Salt Lake City, UT. Milano, Michigan. Modena, Missouri.

Olaparib in People With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: March 16, 2021

Status: Completed

Locations: Bethesda, MD.

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: March 16, 2021

Status: Completed

Locations: Los Angeles, CA. Los Angeles, CA. San Francisco, CA. Boston, MA. Boston, MA. Rochester, MN. New York, NY.

Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: March 13, 2021

Status: Completed

Locations: Bethesda, MD.

Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: March 6, 2021

Status: Completed

Locations: Bethesda, MD.

Diadem to Investigate the Activity and Safety of Durvalumab


Conditions: Mesothelioma

Last Updated: March 3, 2021

Status: Completed

Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: January 20, 2021

Status: Completed

Locations: Rozzano, Michigan.

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: January 20, 2021

Status: Completed

Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: January 19, 2021

Status: Completed

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: January 8, 2021

Status: Completed

Locations: Rochester, MN.

Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C


Conditions: Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Appendiceal Neoplasms, Fever

Last Updated: January 7, 2021

Status: Completed

Locations: Bronx, NY.

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Carcinoma, Non-Small-Cell Lung

Last Updated: December 16, 2020

Status: Completed

Locations: Fayetteville, AR. Augusta, GA. Chicago, IL. Houston, TX.

Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion


Conditions: Mesothelioma, Pleural Effusion, Malignant, Pleural Effusion

Last Updated: December 2, 2020

Status: Completed

Locations: Philadelphia, PA.

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies


Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Melanoma, Small Cell Lung Carcinoma, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms, Triple Negative Breast Neoplasms, Mesothelioma, Squamous Cell Carcinoma of Head and Neck, Microsatellite Instability

Last Updated: October 28, 2020

Status: Completed

Locations: Los Angeles, CA. Hackensack, NJ. Huntersville, NC. Nashville, TN.

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)


Conditions: Mesothelioma

Last Updated: October 28, 2020

Status: Completed

Locations: La Jolla, CA. Aurora, CO. Norwich, CT. Tampa, FL. Chicago, IL. Chicago, IL. New Orleans, LA. Bethesda, MD. Rochester, MN. Buffalo, NY. New York, NY. Durham, NC. Cleveland, OH. Dallas, TX. Houston, TX.

Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: September 30, 2020

Status: Completed

Locations: Dallas, TX.

11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)


Conditions: Mesothelioma

Last Updated: September 29, 2020

Status: Completed

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 28, 2020

Status: Completed

Locations: San Francisco, CA. Tampa, FL. Chicago, IL. Bethesda, MD. Philadelphia, PA.

Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 23, 2020

Status: Completed

Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies


Conditions: Lung Neoplasms, Small Cell Lung Carcinoma, Mesothelioma

Last Updated: September 20, 2020

Status: Completed

Locations: Boston, MA.

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies


Conditions: Neoplasms

Last Updated: August 25, 2020

Status: Completed

Locations: Birmingham, AL. Scottsdale, AZ. Los Angeles, CA. Miami, FL. Ann Arbor, MI. Detroit, MI. Hackensack, NJ. New Brunswick, NJ. New York, NY. Rochester, NY. Huntersville, NC. Portland, OR. Philadelphia, PA. Nashville, TN. Nashville, TN.

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer


Conditions: Lung Neoplasms, Mesothelioma, Thymoma, Thymus Neoplasms

Last Updated: July 30, 2020

Status: Completed

Locations: Los Angeles, CA.

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies


Conditions: Neoplasms, Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pancreatic Neoplasms

Last Updated: July 6, 2020

Status: Completed

Locations: Pittsburgh, PA.

Clinical and Histopathologic Characteristics of BAP1 Mutations


Conditions: Melanoma, Carcinoma, Renal Cell, Mesothelioma, Cholangiocarcinoma, Uveal Neoplasms

Last Updated: June 30, 2020

Status: Completed

Locations: Harrison, NY. New York, NY.

A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas


Conditions: Lymphoma

Last Updated: June 24, 2020

Status: Completed

Locations: San Francisco, CA. Denver, CO. Sarasota, FL. Chicago, IL. Detroit, MI. New York, NY. New York, NY. Huntersville, NC. Pittsburgh, PA. Nashville, TN. Houston, TX.

Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials


Conditions: Mesothelioma

Last Updated: May 22, 2020

Status: Completed

Locations: Bethesda, MD.

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions


Conditions: Mesothelioma, Pleural Effusion, Malignant, Pleural Effusion

Last Updated: May 12, 2020

Status: Completed

Locations: Philadelphia, PA.

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: April 6, 2020

Status: Completed

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: March 31, 2020

Status: Completed

Locations: Philadelphia, PA.

Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.


Conditions: Carcinoma

Last Updated: March 21, 2020

Status: Completed

Gene Therapy for Pleural Malignancies


Conditions: Mesothelioma, Pleural Effusion

Last Updated: March 16, 2020

Status: Completed

Locations: Philadelphia, PA.

Combination Gene Transfer and Chemotherapy


Conditions: Mesothelioma

Last Updated: March 13, 2020

Status: Completed

Locations: Philadelphia, PA.

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer


Conditions: Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Mesothelioma, Thymoma, Thymus Neoplasms

Last Updated: February 27, 2020

Status: Completed

Locations: Philadelphia, PA.

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: February 19, 2020

Status: Completed

Locations: Tucson, AZ. Los Angeles, CA. Marysville, CA. Orange, CA. Pleasanton, CA. Sacramento, CA. Alamosa, CO. Aurora, CO. Edwards, CO. Glenwood Springs, CO. Montrose, CO. Hartford, CT. Gainesville, GA. Decatur, IL. Naperville, IL. Springfield, IL. Beech Grove, IN. Richmond, IN. Chanute, KS. Dodge City, KS. El Dorado, KS. Fort Scott, KS. Independence, KS. Kingman, KS. Lawrence, KS. Liberal, KS. Newton, KS. Parsons, KS. Pratt, KS. Salina, KS. Salina, KS. Wellington, KS. Wichita, KS. Wichita, KS. Wichita, KS. Wichita, KS. Wichita, KS. Winfield, KS. Ann Arbor, MI. Ann Arbor, MI. Ann Arbor, MI. Dearborn, MI. Detroit, MI. Flint, MI. Flint, MI. Grosse Pointe Woods, MI. Jackson, MI. Lansing, MI. Livonia, MI. Pontiac, MI. Port Huron, MI. Saginaw, MI. Warren, MI. Billings, MT. Billings, MT. Billings, MT. Billings, MT. Bozeman, MT. Butte, MT. Great Falls, MT. Great Falls, MT. Havre, MT. Helena, MT. Kalispell, MT. Kalispell, MT. Kalispell, MT. Missoula, MT. Missoula, MT. Albuquerque, NM. Charlotte, NC. Goldsboro, NC. Statesville, NC. Bellefontaine, OH. Chillicothe, OH. Columbus, OH. Columbus, OH. Columbus, OH. Columbus, OH. Columbus, OH. Dayton, OH. Dayton, OH. Dayton, OH. Dayton, OH. Dayton, OH. Delaware, OH. Findlay, OH. Franklin, OH. Greenville, OH. Kettering, OH. Lancaster, OH. Marietta, OH. Mount Vernon, OH. Newark, OH. Springfield, OH. Troy, OH. Westerville, OH. Wilmington, OH. Xenia, OH. Zanesville, OH. Clackamas, OR. Milwaukie, OR. Newberg, OR. Oregon City, OR. Portland, OR. Portland, OR. Portland, OR. Kingsport, TN. Knoxville, TN. Houston, TX. Danville, VA. Norton, VA. Bellingham, WA. Bremerton, WA. Kennewick, WA. Mount Vernon, WA. Poulsbo, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Spokane, WA. Spokane, WA. Vancouver, WA. Vancouver, WA. Wenatchee, WA. Casper, WY. Sheridan, WY.

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors


Conditions: Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms, Mesothelioma, Gastrointestinal Stromal Tumors

Last Updated: February 13, 2020

Status: Completed

Locations: San Francisco, CA. Stanford, CA. Sarasota, FL. Atlanta, GA. Bethesda, MD. Boston, MA. Boston, MA. Boston, MA. New York, NY. New York, NY. Philadelphia, PA. Nashville, TN. Houston, TX.

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)


Conditions: Mesothelioma

Last Updated: January 22, 2020

Status: Completed

Locations: Alessandria, Alabama. Rozzano, Michigan.

Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 8, 2019

Status: Completed

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors


Conditions: Mesothelioma

Last Updated: November 6, 2019

Status: Completed

Locations: Chicago, IL. Bethesda, MD. Detroit, MI. Charleston, SC.

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma


Conditions: Mesothelioma

Last Updated: October 15, 2019

Status: Completed

Locations: New York, NY.

Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers


Conditions: Lung Neoplasms, Mesothelioma

Last Updated: October 3, 2019

Status: Completed

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies


Conditions: Lung Neoplasms, Small Cell Lung Carcinoma, Mesothelioma, Carcinoma, Non-Small-Cell Lung

Last Updated: September 27, 2019

Status: Completed

Locations: Bethesda, MD.

A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma


Conditions: Mesothelioma

Last Updated: September 19, 2019

Status: Completed

Locations: Ventura, CA.

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed


Conditions: Mesothelioma

Last Updated: August 28, 2019

Status: Completed

Locations: Corona, CA. Duarte, CA. Tampa, FL. Baltimore, MD. New York, NY. Philadelphia, PA. Dallas, TX.

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Pleural Effusion

Last Updated: August 5, 2019

Status: Completed

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)


Conditions: Neoplasms

Last Updated: July 16, 2019

Status: Completed

Locations: Birmingham, AL. Anchorage, AK. Phoenix, AZ. Little Rock, AR. Pismo Beach, CA. Sacramento, CA. Denver, CO. Danbury, CT. New Haven, CT. Norwalk, CT. Stamford, CT. Orlando, FL. Marietta, GA. Rome, GA. Honolulu, HI. Chicago, IL. Indianapolis, IN. South Bend, IN. Iowa City, IA. Scarborough, ME. Baltimore, MD. Ann Arbor, MI. Grand Rapids, MI. Kansas City, MO. Kansas City, MO. Las Vegas, NV. Camden, NJ. New Brunswick, NJ. Albuquerque, NM. Albuquerque, NM. Johnson City, NY. Chapel Hill, NC. Hickory, NC. Winston-Salem, NC. Cincinnati, OH. Cleveland, OH. Columbus, OH. Portland, OR. Salem, OR. Philadelphia, PA. Providence, RI. Greenville, SC. Sioux Falls, SD. Chattanooga, TN. Memphis, TN. Nashville, TN. Corpus Christi, TX. Houston, TX. Houston, TX. San Antonio, TX. Murray, UT. Salt Lake City, UT. Winchester, VA. Kennewick, WA. Olympia, WA. Tacoma, WA. Tacoma, WA. Walla Walla, WA. Wenatchee, WA. Milwaukee, WI. Milwaukee, WI.

Malignant Mesothelioma - Can we Improve Quality of Life


Conditions: Mesothelioma

Last Updated: June 12, 2019

Status: Completed

SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma


Conditions: Mesothelioma, Pancreatic Neoplasms, Adenocarcinoma of Lung

Last Updated: June 5, 2019

Status: Completed

Locations: Bethesda, MD.

E-MOSAIC Electronic Tool to Monitor Symptoms


Conditions:

Last Updated: May 14, 2019

Status: Completed

CART-meso in Mesothelin Expressing Cancers


Conditions: Mesothelioma, Carcinoma, Ovarian Epithelial

Last Updated: February 22, 2019

Status: Completed

Locations: Philadelphia, PA.

Chest Wall Motion Analysis in Disease


Conditions: Empyema, Empyema, Pleural, Mesothelioma, Lung Neoplasms, Funnel Chest, Pectus Carinatum, Cystic Fibrosis, Pulmonary Disease, Chronic Obstructive

Last Updated: February 21, 2019

Status: Completed

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM


Conditions: Mesothelioma

Last Updated: January 14, 2019

Status: Completed

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: January 14, 2019

Status: Completed

Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program


Conditions: Carcinoma, Carcinoma, Renal Cell, Mesothelioma, Intestinal Neoplasms, Gastrointestinal Neoplasms

Last Updated: January 10, 2019

Status: Completed

18F-FSPG PET/CT for Cancer Patients on Therapy


Conditions: Breast Neoplasms, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Carcinoma, Renal Cell, Lymphoma, B-Cell

Last Updated: December 11, 2018

Status: Completed

Locations: Stanford, CA.

Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma


Conditions: Neoplasms, Mesothelioma, Lung Neoplasms

Last Updated: December 11, 2018

Status: Completed

WT-1 Analog Peptide Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy


Conditions: Mesothelioma

Last Updated: November 1, 2018

Status: Completed

Locations: New York, NY.

Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma


Conditions: Mesothelioma

Last Updated: September 17, 2018

Status: Completed

Locations: Chicago, IL.

The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma


Conditions: Neoplasms, Mesothelioma, Parathyroid Neoplasms, Pleural Neoplasms, Thyroid Neoplasms, Pneumothorax, Thyroid Diseases

Last Updated: July 20, 2018

Status: Completed

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 11, 2018

Status: Completed

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)


Conditions: Colonic Neoplasms, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Carcinoma, Ovarian Epithelial, Germinoma, Ovarian Neoplasms, Lung Neoplasms, Pseudomyxoma Peritonei

Last Updated: July 2, 2018

Status: Completed

Locations: Winston-Salem, NC.

Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: June 12, 2018

Status: Completed

A Study in Non Small Cell Lung Cancer


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung

Last Updated: May 16, 2018

Status: Completed

PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: May 4, 2018

Status: Completed

Locations: Duarte, CA.

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy


Conditions: Mesothelioma

Last Updated: March 13, 2018

Status: Completed

Locations: Bethesda, MD.

Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: December 30, 2017

Status: Completed

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: December 27, 2017

Status: Completed

Locations: San Antonio, TX.

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors


Conditions: Mesothelioma

Last Updated: November 27, 2017

Status: Completed

Locations: Minneapolis, MN.

Do Your Genes Put You at a Higher Risk of Developing Mesothelioma


Conditions: Mesothelioma

Last Updated: November 3, 2017

Status: Completed

Locations: Baltimore, MD. Rochester, MN. New York, NY. New York, NY. Winston-Salem, NC. Philadelphia, PA.

Autologous Redirected RNA Meso-CIR T Cells


Conditions: Mesothelioma

Last Updated: September 16, 2017

Status: Completed

Locations: Philadelphia, PA.

Nivolumab in Patients With Recurrent Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: September 13, 2017

Status: Completed

Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)


Conditions: Mesothelioma

Last Updated: July 17, 2017

Status: Completed

Locations: Houston, TX.

Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.


Conditions: Mesothelioma, Neoplasm Metastasis, Pancreatic Neoplasms

Last Updated: July 6, 2017

Status: Completed

Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.


Conditions: Mesothelioma

Last Updated: June 8, 2017

Status: Completed

Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)


Conditions: Mesothelioma

Last Updated: April 24, 2017

Status: Completed

Locations: Birmingham, AL.

MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma

Last Updated: April 5, 2017

Status: Completed

Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: February 27, 2017

Status: Completed

Thrombin Generation and Platelet Activation in CRS/HIPEC


Conditions: Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pseudomyxoma Peritonei

Last Updated: January 24, 2017

Status: Completed

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: December 5, 2016

Status: Completed

Locations: Mobile, AL. Scottsdale, AZ. Jacksonville, FL. Peoria, IL. Urbana, IL. Cedar Rapids, IA. Des Moines, IA. Sioux City, IA. Wichita, KS. New Orleans, LA. Ann Arbor, MI. Duluth, MN. Rochester, MN. Saint Cloud, MN. Saint Louis Park, MN. Omaha, NE. Bismarck, ND. Fargo, ND. Toledo, OH. Danville, PA. Spartanburg, SC. Rapid City, SD. Sioux Falls, SD. Green Bay, WI.

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases


Conditions: Rare Diseases

Last Updated: November 16, 2016

Status: Completed

Collecting Tumor Samples From Patients With Gynecological Tumors


Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Rhabdomyosarcoma, Germinoma, Leiomyosarcoma, Vulvar Neoplasms, Vaginal Neoplasms, Cystadenocarcinoma, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Carcinoma, Adenosquamous, Cystadenocarcinoma, Serous, Brenner Tumor, Sarcoma, Endometrial Stromal, Rhabdomyosarcoma, Embryonal

Last Updated: October 26, 2016

Status: Completed

Locations: Fayetteville, AR. Fayetteville, AR. Little Rock, AR. Burbank, CA. Long Beach, CA. Los Angeles, CA. Orange, CA. Palo Alto, CA. Sacramento, CA. San Francisco, CA. Sylmar, CA. Aurora, CO. Aurora, CO. Danbury, CT. Hartford, CT. New Britain, CT. New Haven, CT. Fort Lauderdale, FL. Fort Myers, FL. Jupiter, FL. Miami, FL. Atlanta, GA. Augusta, GA. Gainesville, GA. Savannah, GA. Chicago, IL. Chicago, IL. Chicago, IL. Oak Lawn, IL. Springfield, IL. Indianapolis, IN. Indianapolis, IN. South Bend, IN. Clive, IA. Clive, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Iowa City, IA. West Des Moines, IA. West Des Moines, IA. Ashland, KY. Edgewood, KY. Lexington, KY. Louisville, KY. Baton Rouge, LA. New Orleans, LA. Shreveport, LA. Portland, ME. Baltimore, MD. Baltimore, MD. Bethesda, MD. Springfield, MA. Worcester, MA. Worcester, MA. Ann Arbor, MI. Detroit, MI. Flint, MI. Grand Rapids, MI. Minneapolis, MN. Jackson, MS. Jackson, MS. Kessler AFB, MS. Columbia, MO. Saint Louis, MO. Saint Louis, MO. Springfield, MO. Springfield, MO. Springfield, MO. Omaha, NE. Las Vegas, NV. Las Vegas, NV. Lebanon, NH. Camden, NJ. Hackensack, NJ. Hackensack, NJ. Newark, NJ. Albuquerque, NM. Buffalo, NY. Mineola, NY. New York, NY. New York, NY. Stony Brook, NY. Chapel Hill, NC. Charlotte, NC. Charlotte, NC. Greenville, NC. Greenville, NC. Greenville, NC. Pinehurst, NC. Winston-Salem, NC. Akron, OH. Cincinnati, OH. Cincinnati, OH. Cleveland, OH. Columbus, OH. Columbus, OH. Mentor, OH. Oklahoma City, OK. Tulsa, OK. Tulsa, OK. Portland, OR. Portland, OR. Abington, PA. Allentown, PA. Bethlehem, PA. Danville, PA. Philadelphia, PA. Philadelphia, PA. Pittsburgh, PA. Pittsburgh, PA. State College, PA. Wilkes-Barre, PA. Providence, RI. Charleston, SC. Greenville, SC. Spartanburg, SC. Rapid City, SD. Sioux Falls, SD. Sioux Falls, SD. Sioux Falls, SD. Chattanooga, TN. Johnson City, TN. Knoxville, TN. Memphis, TN. Nashville, TN. Nashville, TN. Amarillo, TX. Austin, TX. Dallas, TX. Dallas, TX. Dallas, TX. Dallas, TX. Fort Sam Houston, TX. Galveston, TX. Houston, TX. Lackland AFB, TX. Lubbock, TX. Lubbock, TX. Temple, TX. Hampton, VA. Roanoke, VA. Auburn, WA. Centralia, WA. Federal Way, WA. Lakewood, WA. Olympia, WA. Olympia, WA. Puyallup, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Chippewa Falls, WI. Eau Claire, WI. Eau Claire, WI. Ladysmith, WI. Madison, WI. Marshfield, WI. Marshfield, WI. Milwaukee, WI. Milwaukee, WI. Milwaukee, WI. Minocqua, WI. Rhinelander, WI. Rice Lake, WI. Stevens Point, WI. Stevens Point, WI. Wausau, WI. West Allis, WI. Weston, WI. Weston, WI. Wisconsin Rapids, WI.

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers


Conditions: Mesothelioma

Last Updated: September 28, 2016

Status: Completed

Locations: Bethesda, MD.

Mesothelioma Avastin Plus Pemetrexed-cisplatin Study


Conditions: Mesothelioma

Last Updated: September 1, 2016

Status: Completed

Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays


Conditions: Mesothelioma

Last Updated: July 25, 2016

Status: Completed

Capecitabine in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 12, 2016

Status: Completed

Locations: Birmingham, AL. La Jolla, CA. San Francisco, CA. San Francisco, CA. Wilmington, DE. Miami Beach, FL. Chicago, IL. Chicago, IL. Chicago, IL. Bettendorf, IA. Iowa City, IA. Togus, ME. Baltimore, MD. Boston, MA. Worcester, MA. Minneapolis, MN. Minneapolis, MN. Columbia, MO. Columbia, MO. Saint Louis, MO. Omaha, NE. Las Vegas, NV. Lebanon, NH. Buffalo, NY. Buffalo, NY. Manhasset, NY. Manhasset, NY. New York, NY. New York, NY. New York, NY. Syracuse, NY. Syracuse, NY. Syracuse, NY. Chapel Hill, NC. Durham, NC. Durham, NC. Winston-Salem, NC. Winston-Salem, NC. Columbus, OH. Providence, RI. Charleston, SC. Memphis, TN. Memphis, TN. Bennington, VT. Burlington, VT. White River Junction, VT. Richmond, VA. Richmond, VA.

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 11, 2016

Status: Completed

Locations: La Jolla, CA. San Francisco, CA. Lewes, DE. Newark, DE. Orlando, FL. Savannah, GA. Chicago, IL. Elkhart, IN. Fort Wayne, IN. Kokomo, IN. La Porte, IN. South Bend, IN. South Bend, IN. South Bend, IN. South Bend, IN. Baltimore, MD. Elkton MD, MD. Boston, MA. Boston, MA. St. Joseph, MI. Minneapolis, MN. Saint Louis, MO. Saint Louis, MO. Omaha, NE. Voorhees, NJ. Syracuse, NY. Durham, NC. Goldsboro, NC. Kinston, NC. Statesville, NC. Winston-Salem, NC. Columbus, OH. Greenville, SC. Berlin, VT. Burlington, VT. Danville, VA.

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: June 30, 2016

Status: Completed

Locations: Anniston, AL. Birmingham, AL. La Jolla, CA. Los Angeles, CA. San Diego, CA. San Diego, CA. San Francisco, CA. San Francisco, CA. Newark, DE. Fort Lauderdale, FL. Hollywood, FL. Miami Beach, FL. Orlando, FL. Chicago, IL. Chicago, IL. Chicago, IL. Chicago, IL. Peoria, IL. River Forest, IL. Fort Wayne, IN. South Bend, IN. Iowa City, IA. Louisville, KY. Baltimore, MD. Boston, MA. Worcester, MA. Saint Joseph, MI. Minneapolis, MN. Minneapolis, MN. Columbia, MO. Columbia, MO. Kansas City, MO. Saint Louis, MO. Saint Louis, MO. Omaha, NE. Las Vegas, NV. Las Vegas, NV. Hooksett, NH. Lebanon, NH. Camden, NJ. Buffalo, NY. Buffalo, NY. East Syracuse, NY. Elmhurst, NY. Jamaica, NY. Manhasset, NY. Manhasset, NY. New York, NY. New York, NY. New York, NY. Syracuse, NY. Syracuse, NY. Asheville, NC. Chapel Hill, NC. Concord, NC. Durham, NC. Durham, NC. Fayetteville, NC. Goldsboro, NC. Kinston, NC. Pinehurst, NC. Wilmington, NC. Winston-Salem, NC. Columbus, OH. Oklahoma City, OK. Pittsburgh, PA. Providence, RI. Memphis, TN. Memphis, TN. Dallas, TX. Dallas, TX. Burlington, VT. Charlottesville, VA. Norfolk, VA. Richmond, VA. Roanoke, VA. Huntington, WV.

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)


Conditions: Mesothelioma

Last Updated: May 29, 2016

Status: Completed

Tomotherapy Treatment for Mesothelioma


Conditions: Mesothelioma

Last Updated: April 5, 2016

Status: Completed

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma


Conditions: Leukemia, Lung Neoplasms, Preleukemia, Mesothelioma, Myelodysplastic Syndromes, Syndrome

Last Updated: February 2, 2016

Status: Completed

Locations: New York, NY.

B-Receptor Signaling in Cardiomyopathy


Conditions: Carcinoma, Multiple Myeloma, Sarcoma, Preleukemia, Urinary Bladder Neoplasms, Mesothelioma, Neuroendocrine Tumors, Cholangiocarcinoma, Gastrointestinal Stromal Tumors, Hodgkin Disease, Anus Neoplasms, Carcinoma, Transitional Cell, Lymphoma, Non-Hodgkin, Testicular Neoplasms, Bone Neoplasms, Gallbladder Neoplasms, Eye Neoplasms, Endocrine Gland Neoplasms, Thymus Neoplasms, Brain Neoplasms, Carcinoma, Renal Cell, Stomach Neoplasms, Cardiomyopathies, Myelodysplastic Syndromes, Myeloproliferative Disorders, Amyloidosis

Last Updated: November 16, 2015

Status: Completed

Locations: Stanford, CA.

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: November 16, 2015

Status: Completed

Locations: Houston, TX.

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 13, 2015

Status: Completed

Locations: Birmingham, AL. La Jolla, CA. Los Angeles, CA. San Francisco, CA. Aurora, CO. Newark, DE. Atlanta, GA. Chicago, IL. Baltimore, MD. Bethesda, MD. New York, NY. Morgantown, WV.

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy


Conditions: Neoplasms, Mesothelioma, Colonic Neoplasms, Peritoneal Neoplasms, Abdominal Neoplasms

Last Updated: October 19, 2015

Status: Completed

Locations: Bethesda, MD.

Intrapleural Gene Transfer for Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 21, 2015

Status: Completed

Locations: Philadelphia, PA.

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma


Conditions: Lymphoma

Last Updated: July 7, 2015

Status: Completed

Locations: New Haven, CT. New York, NY. New York, NY. Houston, TX.

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors


Conditions: Neoplasms

Last Updated: July 7, 2015

Status: Completed

Locations: Scottsdale, AZ. Omaha, NE. Portsmouth, NH.

Isolated Thoracic Perfusion (ITP-F) for MPM


Conditions: Mesothelioma

Last Updated: June 9, 2015

Status: Completed

Immunotoxin Therapy in Treating Patients With Advanced Cancer


Conditions: Lung Neoplasms, Pancreatic Neoplasms, Head and Neck Neoplasms, Uterine Cervical Neoplasms, Mesothelioma, Fallopian Tube Neoplasms

Last Updated: April 29, 2015

Status: Completed

Locations: Bethesda, MD.

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors


Conditions: Lung Neoplasms, Pancreatic Neoplasms, Head and Neck Neoplasms, Uterine Cervical Neoplasms, Mesothelioma, Fallopian Tube Neoplasms

Last Updated: April 29, 2015

Status: Completed

Locations: Bethesda, MD. Winston-Salem, NC.

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura


Conditions: Lung Neoplasms, Esophageal Neoplasms, Mesothelioma

Last Updated: April 28, 2015

Status: Completed

Locations: Bethesda, MD. Bethesda, MD.

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity


Conditions: Mesothelioma

Last Updated: April 21, 2015

Status: Completed

Locations: Boston, MA. New York, NY. Philadelphia, PA.

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: February 11, 2015

Status: Completed

Pazopanib in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: January 28, 2015

Status: Completed

Locations: Rochester, MN.

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: December 30, 2014

Status: Completed

Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients


Conditions: Mesothelioma

Last Updated: December 1, 2014

Status: Completed

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 25, 2014

Status: Completed

Locations: Chicago, IL.

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation


Conditions: Neoplasms, Melanoma, Small Cell Lung Carcinoma, Colorectal Neoplasms, Ovarian Neoplasms, Liposarcoma

Last Updated: July 23, 2014

Status: Completed

Locations: New York, NY.

A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Ovarian Neoplasms, Mesothelioma

Last Updated: July 16, 2014

Status: Completed

Locations: Baltimore, MD. Bethesda, MD. Philadelphia, PA.

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: May 5, 2014

Status: Completed

Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate


Conditions: Mesothelioma

Last Updated: March 26, 2014

Status: Completed

Locations: Boston, MA. Boston, MA.

Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: March 26, 2014

Status: Completed

Locations: Boston, MA. Boston, MA.

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite


Conditions: Mesothelioma

Last Updated: March 4, 2014

Status: Completed

Locations: Detroit, MI.

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: February 26, 2014

Status: Completed

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: February 10, 2014

Status: Completed

Locations: Chicago, IL.

Rapamycin With Grapefruit Juice for Advanced Malignancies


Conditions: Neoplasm Metastasis

Last Updated: January 16, 2014

Status: Completed

Locations: Chicago, IL.

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain


Conditions: Cancer Pain

Last Updated: January 14, 2014

Status: Completed

Locations: Chandler, AZ.

Serum Biomarkers in Diagnosis of Mesothelioma


Conditions: Mesothelioma

Last Updated: January 6, 2014

Status: Completed

Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms, Postoperative Complications

Last Updated: December 18, 2013

Status: Completed

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: August 6, 2013

Status: Completed

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors


Conditions: Carcinoma, Sarcoma, Liver Neoplasms, Mesothelioma, Nervous System Neoplasms, Central Nervous System Neoplasms, Pheochromocytoma, Adrenocortical Carcinoma

Last Updated: July 9, 2013

Status: Completed

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer


Conditions: Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Mesothelioma, Kidney Neoplasms

Last Updated: July 9, 2013

Status: Completed

Locations: Los Angeles, CA.

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: June 27, 2013

Status: Completed

Alanosine in Treating Patients With Cancer


Conditions: Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Mesothelioma

Last Updated: June 25, 2013

Status: Completed

Locations: Birmingham, AL. Tucson, AZ. La Verne, CA. Los Angeles, CA. Boca Raton, FL. Chicago, IL. Skokie, IL. New York, NY. New York, NY. Nashville, TN. Houston, TX. Houston, TX.

Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: June 17, 2013

Status: Completed

Locations: New Brunswick, NJ. New York, NY. Cleveland, OH.

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: June 4, 2013

Status: Completed

Locations: Chicago, IL. Boston, MA.

SU5416 in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: May 31, 2013

Status: Completed

Locations: Chicago, IL. Chicago, IL. Chicago, IL. Decatur, IL. Evanston, IL. Park Ridge, IL. Peoria, IL. Springfield, IL. Fort Wayne, IN. South Bend, IN.

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: April 16, 2013

Status: Completed

Locations: Marrero, LA. Philadelphia, PA. Newport News, VA.

Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)


Conditions: Mesothelioma, Fever

Last Updated: March 15, 2013

Status: Completed

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: January 23, 2013

Status: Completed

Locations: San Antonio, TX.

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction


Conditions: Carcinoma, Breast Neoplasms, Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Pancreatic Neoplasms, Glioblastoma, Rectal Neoplasms, Glioma, Head and Neck Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Astrocytoma, Mesothelioma, Carcinoma, Ovarian Epithelial, Laryngeal Neoplasms, Oropharyngeal Neoplasms, Carcinoma, Basal Cell, Carcinoma, Verrucous, Ependymoma, Gliosarcoma, Papilloma, Salivary Gland Neoplasms, Oligodendroglioma, Nasopharyngeal Carcinoma, Paranasal Sinus Neoplasms, Anus Neoplasms, Carcinoma, Adenoid Cystic, Neoplasms, Unknown Primary, Breast Neoplasms, Male, Carcinoma, Mucoepidermoid, Esthesioneuroblastoma, Olfactory, Papilloma, Inverted, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Laryngeal Diseases, Granuloma

Last Updated: January 15, 2013

Status: Completed

Locations: Chicago, IL.

Gefitinib in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: January 15, 2013

Status: Completed

Locations: Chicago, IL.

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 30, 2012

Status: Completed

Locations: Norwich, CT. Lewes, DE. Newark, DE. Jacksonville, FL. Altanta, GA. Aurora, IL. Bloomington, IL. Canton, IL. Carthage, IL. Decatur, IL. Eureka, IL. Galesburg, IL. Galesburg, IL. Havana, IL. Hopedale, IL. Joliet, IL. Kewanee, IL. Macomb, IL. Moline, IL. Normal, IL. Normal, IL. Ottawa, IL. Ottawa, IL. Pekin, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peru, IL. Princeton, IL. Spring Valley, IL. Springfield, IL. Urbana, IL. Urbana, IL. Elkhart, IN. Indianapolis, IN. Indianapolis, IN. Indianapolis, IN. Kokomo, IN. La Porte, IN. Michigan City, IN. South Bend, IN. South Bend, IN. South Bend, IN. Ames, IA. Cedar Rapids, IA. Sioux City, IA. Sioux City, IA. Sioux City, IA. Baltimore, MD. Elkton MD, MD. Ann Arbor, MI. Ann Arbor, MI. Dearborn, MI. Flint, MI. Flint, MI. Grosse Pointe Woods, MI. Jackson, MI. Kalamazoo, MI. Kalamazoo, MI. Kalamazoo, MI. Lansing, MI. Saginaw, MI. St. Joseph, MI. Warren, MI. Burnsville, MN. Coon Rapids, MN. Duluth, MN. Duluth, MN. Duluth, MN. Edina, MN. Fridley, MN. Hutchinson, MN. Lichfield, MN. Maplewood, MN. Maplewood, MN. Minneapolis, MN. Minneapolis, MN. Robbinsdale, MN. Rochester, MN. Saint Louis Park, MN. Shakopee, MN. St Paul, MN. St. Louis Park, MN. St. Paul, MN. St. Paul, MN. Waconia, MN. Woodbury, MN. Woodbury, MN. East Orange, NJ. Hackensack, NJ. Marlton, NJ. New Brunswick, NJ. Voorhees, NJ. Voorhees, NJ. Bismarck, ND. Bismarck, ND. Bismarck, ND. Bismarck, ND. Akron, OH. Canton, OH. Cleveland, OH. Lima, OH. Allentown, PA. Hershey, PA. Lewistown, PA. Philadelphia, PA. Philadelphia, PA. State College, PA. Sioux Falls, SD. Sioux Falls, SD. Sioux Falls, SD. La Crosse, WI. Madison, WI.

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: October 5, 2012

Status: Completed

Locations: Mobile, AL. Phoenix, AZ. Phoenix, AZ. Tucson, AZ. Tucson, AZ. Little Rock, AR. Little Rock, AR. Long Beach, CA. Los Angeles, CA. Los Angeles, CA. Los Angeles, CA. Martinez, CA. Oakland, CA. Sacramento, CA. San Francisco, CA. Santa Rosa, CA. Travis Air Force Base, CA. Denver, CO. Denver, CO. Atlanta, GA. Fort Gordon, GA. Honolulu, HI. Decatur, IL. Hines, IL. Maywood, IL. Kansas City, KS. Wichita, KS. Wichita, KS. Lexington, KY. Lexington, KY. New Orleans, LA. New Orleans, LA. New Orleans, LA. Shreveport, LA. Shreveport, LA. Boston, MA. Jamaica Plain, MA. Ann Arbor, MI. Ann Arbor, MI. Detroit, MI. Detroit, MI. Detroit, MI. Grand Rapids, MI. Southfield, MI. Biloxi, MS. Jackson, MS. Jackson, MS. Keesler AFB, MS. Kansas City, MO. Kansas City, MO. Saint Louis, MO. Saint Louis, MO. Springfield, MO. Billings, MT. Albuquerque, NM. Albuquerque, NM. Brooklyn, NY. New York, NY. Cincinnati, OH. Cincinnati, OH. Cleveland, OH. Columbus, OH. Dayton, OH. Kettering, OH. Oklahoma City, OK. Oklahoma City, OK. Portland, OR. Portland, OR. Portland, OR. Greenville, SC. Spartanburg, SC. Fort Sam Houston, TX. Galveston, TX. Lubbock, TX. San Antonio, TX. San Antonio, TX. Temple, TX. Temple, TX. Salt Lake City, UT. Salt Lake City, UT. Seattle, WA. Seattle, WA. Seattle, WA. Tacoma, WA.

Interleukin-12 in Treating Patients With Cancer in the Abdomen


Conditions: Colorectal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Anus Neoplasms, Gallbladder Neoplasms

Last Updated: July 27, 2012

Status: Completed

Locations: Houston, TX.

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 17, 2012

Status: Completed

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 17, 2012

Status: Completed

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: June 5, 2012

Status: Completed

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung


Conditions: Mesothelioma

Last Updated: May 14, 2012

Status: Completed

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs


Conditions: Lung Neoplasms, Mesothelioma

Last Updated: March 14, 2012

Status: Completed

Locations: Bethesda, MD.

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma


Conditions: Lymphoma

Last Updated: March 14, 2012

Status: Completed

Locations: Bethesda, MD. Bethesda, MD. Bethesda, MD.

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma


Conditions: Mesothelioma

Last Updated: December 23, 2011

Status: Completed

Locations: Chicago, IL. Boston, MA. Boston, MA.

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors


Conditions:

Last Updated: September 26, 2011

Status: Completed

Locations: Tampa, FL.

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer


Conditions:

Last Updated: April 23, 2011

Status: Completed

Locations: New York, NY.

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: March 25, 2011

Status: Completed

Locations: New York, NY. Houston, TX.

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma


Conditions: Lung Neoplasms, Mesothelioma

Last Updated: March 3, 2011

Status: Completed

Locations: Buffalo, NY.

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: February 25, 2011

Status: Completed

Locations: Buffalo, NY.

Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment


Conditions: Mesothelioma

Last Updated: November 17, 2010

Status: Completed

Dendritic Cell-based Immunotherapy in Mesothelioma


Conditions: Mesothelioma

Last Updated: November 15, 2010

Status: Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.


Conditions: Carcinoma, Sarcoma, Mesothelioma, Breast Neoplasms, Endometrial Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Esophageal Neoplasms, Testicular Neoplasms, Small Cell Lung Carcinoma, Carcinoma, Neuroendocrine

Last Updated: August 2, 2010

Status: Completed

Locations: Tuscon, AZ. Tampa, FL. Sparks, NV. Lebanon, NH.

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen


Conditions: Lung Neoplasms, Mesothelioma

Last Updated: June 10, 2010

Status: Completed

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 17, 2009

Status: Completed

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma


Conditions: Mesothelioma, Pleural Neoplasms

Last Updated: May 1, 2009

Status: Completed

Locations: San Francisco, CA. Chicago, IL. Baltimore, MD. Boston, MA. Detroit, MI. New York, NY. Houston, TX.

Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy


Conditions: Pleural Effusion, Pleural Diseases

Last Updated: July 22, 2008

Status: Completed

Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 5, 2007

Status: Completed

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: April 10, 2007

Status: Completed

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma


Conditions: Mesothelioma

Last Updated: January 24, 2007

Status: Completed

Locations: Aurora, CO. Tampa, FL. Chicago, IL. Boston, MA. Detroit, MI. Albuquerque, NM. New York, NY. Cleveland, OH. Philadelphia, PA. Pittsburgh, PA.

Get Help Contacting



    Privacy policy: All information is secure and will never be released

    TRUSTe